AMRX AMNEAL PHARMACEUTICALS INC
2026Q1 · CUSIP 03168L105 · Sector: Healthcare & Biotech
Lit · Institutions accelerating in
Holders
313
Δ holders QoQ
+35
Breadth percentile
Top 8%
Whale holders
151
Δ whales
+10
Inst. holding value
$2.0B
New positions
78
Closed positions
43
Price momentum (1Q)
-21.5%
Put / Call
2/1
Breadth history (34 quarters)
Past Lit Events & Aftermath 7 lit events
| Period | Percentile | Next-1Q return | Next-2Q return |
|---|---|---|---|
| 2026Q1 | Top 8% | — | — |
| 2025Q4 | Top 19% | -21.5% | — |
| 2025Q1 | Top 4% | +24.4% | +54.4% |
| 2024Q1 | Top 13% | +19.5% | +24.2% |
| 2023Q3 | Top 12% | +32.3% | +54.0% |
| 2022Q1 | Top 14% | -30.3% | -37.8% |
| 2021Q1 | Top 13% | -14.0% | -9.9% |
Options Sentiment
Put holders
2
QoQ: +1
Call holders
1
QoQ: -1
See methodology →
Fundamentals
PE (TTM)
48.2
EPS (TTM)
$0.37
EPS YoY
—
Revenue (TTM)
$3.0B
Revenue YoY
+7.6%
Net margin
4.0%
ROE
—
Debt ratio
101.3%
FCF (TTM)
$241M
Dividend (TTM)
No dividend
Quarterly Revenue & EPS (4Y)
Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable
P/E (TTM) over time
P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden
As of 2026-03-31 · SEC filings (XBRL)
Get the next update
2026Q2 holdings publish around Aug 15 — subscribe to receive the lists first.